Phosphatidylserine Supplier Quality Agreements: Change Control and Notification Clauses for PS Buyers

Most phosphatidylserine buyers have a supply agreement and a specification sheet. Very few have a supplier quality agreement — the document that defines, in operational detail, how the two companies' quality systems connect. The difference becomes visible the first time a supplier quietly changes something: a raw material source, a filtration step, the nitrogen flush on a drum liner, or the contract laboratory that runs release testing.

For a specialised ingredient like PS, silent change is expensive. Your label, your customer approvals, your retail audit files, and your regulatory position can all depend on details the supplier controls — the soy or sunflower origin, the enzyme system used in conversion, the solvent residue profile, the packaging materials in contact with the powder. This article sets out what a PS quality agreement should contain, with particular attention to change control: the clause set that obliges a supplier to tell you before the material changes, not after.

What a Quality Agreement Covers That a Supply Contract Does Not

A supply contract answers commercial questions: volumes, price, lead times, payment, liability. A quality agreement answers manufacturing and control questions: which site produces the material, which processes are validated, which tests are performed at release, who performs them, how deviations are handled, and what happens when anything about the product or process changes.

Under the US dietary supplement GMP framework (21 CFR Part 111), supplement manufacturers must establish supplier qualification and verify that incoming components meet specifications — and a quality agreement is the cleanest way to put the supplier's obligations in enforceable writing. Under EU practice, the same logic applies through food safety management requirements and customer-supplier quality expectations in B2B supply.

A workable SQA for PS typically covers: the named manufacturing site(s) and a prohibition on site transfer without notification; process description at defined boundaries; raw material sources (soy or sunflower lecithin feedstock, enzyme preparations) with an obligation to disclose origin; release testing scope and methods, and whether testing is in-house or contracted out; stability program and retest or expiry dating; specifications attached as a controlled annex; packaging materials and contact surfaces; retention samples; deviation and complaint handling; audit rights; and change notification, which deserves its own section in the document.

Specification Governance: Who Owns the Numbers

The specification annex is where quality agreements earn their keep. Three governance points matter. First, version control: the spec in force is the one attached to the agreement, and any revision follows the change-notification procedure, not an email from a salesperson. Second, method agreement: when your incoming lab result disagrees with the supplier's COA, the dispute is often methodological — different HPLC methods for phospholipid assay, different handling of water content, different sampling plans. The SQA should name the release methods or a mutually accepted arbitration method. Third, acceptance criteria ownership: buyers importing PS into formulations with tight sensory or performance windows (colour, dispersion, peroxide value limits, pH of dispersion) should set those tighter limits in the annex rather than accepting a generic industry spec that permits a range wider than their product tolerates.

Change Control and Prior-Notification Clauses

Change notification is the heart of the agreement. The structure that works is a change matrix: a list of change categories, each classified as either "notify before implementation" or "notify within X days of implementation." Changes that deserve prior notification for a PS supply include: change of manufacturing site or contract manufacturing use; change of raw material source or supplier of the lecithin feedstock; change of enzyme preparation or immobilisation system; change of process parameters that affect the impurity or solvent-residue profile; change of packaging materials in product contact; change of release testing laboratory or critical method; and change of ownership or management of the quality unit.

Then define the notification itself: written, with an assessment of impact on specifications, stability, and regulatory status; supporting data attached where relevant; and a defined transition point — typically first lot after notification, or after the buyer's written acceptance for changes the buyer has designated as acceptance-required. The agreement should also give the buyer the right to reject the change and, for material changes, to requalify before shipping continues. Without that last element, "notification" degenerates into advance warning of something you must still accept.

Handling Discrepancies, Investigations, and CAPA

When an incoming result fails or drifts, the SQA defines the mechanism: timeframe for the supplier to acknowledge the discrepancy (commonly three to five business days), the supplier's obligation to investigate and provide a written root-cause assessment, correction and preventive action commitments, and the disposition rules for affected lots — including whether the supplier bears the cost of retesting, return, or replacement. The same section should cover complaints from your customers that trace back to the ingredient, retention-sample testing to arbitrate disputes, and the buyer's right to receive the supplier's investigation report, at least in summary. Buyers sometimes hesitate to demand CAPA participation from an overseas supplier; in practice, serious PS manufacturers operate deviation systems internally already, and a quality agreement simply connects yours to theirs.

Audits, Document Access, and Enforcement

The agreement should grant audit rights proportionate to risk: full on-site audits at a defined frequency, for-cause audits after significant events, and remote or document-based audits in between — plus access to the documents your customers will ask for: site master file summaries, certification copies, method validation summaries, and change notifications. Enforcement provisions matter as much as rights: a cure period for breaches, suspension of orders while a critical deviation is open, termination rights tied to quality events (repeated unnotified changes, falsified documentation, loss of certification), and a statement that quality-agreement obligations survive contract renewal cycles. One practical test of any SQA: if a supplier changes their drum liner resin tomorrow, how many clauses, and whose signatures, does that change touch? A well-drafted agreement answers in one sentence.

Preguntas frecuentes

Q: Is a quality agreement separate from the supply contract, or a clause inside it?

A: Either structure works, but a separate document signed by both quality functions is the norm in ingredient supply. The supply contract then references it as binding. The separation keeps quality obligations stable even when commercial terms are renegotiated.

Q: Which changes most often catch PS buyers by surprise?

A: In practice: raw material feedstock origin changes (soy to sunflower or between origins), packaging and desiccant changes, contract laboratory switches, and silent spec revisions dressed up as "updated COA formats." Each affects compliance or performance downstream, which is why the change matrix should name them explicitly.

Q: Our supplier is in Asia and audits are expensive. Can we rely on document audits?

A: For a qualified, stable relationship, alternating full on-site audits with interim document or remote audits is a defensible pattern most quality organisations accept. Keep for-cause audit rights for events such as significant deviations, unnotified changes, or regulatory findings.

Q: What is a reasonable notification period before a supplier implements a change?

A: Commonly 60 to 90 days for changes affecting product characteristics or compliance, and 30 days for administrative or documentation changes. The period should be long enough for you to assess impact, run confirmation testing, and adjust your own filings if needed.

Conclusión

A phosphatidylserine supply relationship held together only by a price agreement and a COA is one unnotified change away from a compliance problem. A quality agreement with a real change-control matrix, specification governance, discrepancy handling, and enforceable audit rights converts the supplier's quality system from a black box into an extension of your own. Suppliers who resist such agreements are telling you something; suppliers who operate under them daily are, too. Nutranexa signs and operates under customer quality agreements as standard practice, provides structured change notifications for every PS supply program, and supports customer audits with complete documentation access.

Fuentes

• U.S. FDA — Current Good Manufacturing Practice for Dietary Supplements (21 CFR Part 111): https://www.fda.gov/food/current-good-manufacturing-practice-cgmp-dietary-supplements
• U.S. FDA — Dietary supplements guidance documents and regulatory information: https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information
• NSF — NSF/ANSI 173 Dietary Supplements Standard: https://www.nsf.org/standards-development/nsf-national-standards/nsf-ansi-173
• ICH — Q10 Pharmaceutical Quality System (change management principles): https://www.ich.org/page/quality-guidelines
• European Commission — Food Safety portal: https://food.ec.europa.eu/index_en

Próximos pasos recomendados

• Revisa el Phosphatidylserine página del producto.
• Comparar Soy PS y Sunflower PS.
• Verificar prueba de fabricación y Calidad e I+D.